Literature DB >> 3236152

Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies.

R Bodmeier1, J W McGinity.   

Abstract

Poly(dl-lactide) (PLA) microspheres containing quinidine or quinidine sulphate were prepared by the emulsification-solvent evaporation technique. The in vitro release profile of quinidine or quinidine sulphate from the microspheres was characterized by three phases: a lag time, a rapid release phase (burst), and a slow release phase. Drug release was studied as a function of the ionic strength of the dissolution medium, to demonstrate the importance of the water imbition into the microspheres which induced the drug release. The lag time increased with increasing ionic strength. The microspheres stayed intact during the dissolution study as shown by scanning electron microscopy (SEM). Disintegration of microspheres which was initially observed was an artifact introduced during the SEM procedure. The high vacuum applied either during the coating of the microspheres with gold-palladium or during the actual observation in the scanning electron microscope caused the microspheres to collapse or rupture.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3236152     DOI: 10.3109/02652048809036729

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  3 in total

1.  Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes.

Authors:  Jun Zhou; Yi-Ting Tsai; Hong Weng; David W Baker; Liping Tang
Journal:  Biomaterials       Date:  2011-09-03       Impact factor: 12.479

2.  Impact of dispersion time interval and particle size on release profiles of propranolol HCl and carbamazepines from microparticle blends system.

Authors:  Muhaimin Muhaimin; Anis Yohana Chaerunisaa; Roland Bodmeier
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

3.  Development of sustained-release microspheres for the delivery of SAR 1118, an LFA-1 antagonist intended for the treatment of vascular complications of the eye.

Authors:  Sarath Yandrapu; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-20       Impact factor: 2.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.